Literature DB >> 15942875

Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.

Katrina Tatton-Brown1, Jenny Douglas, Kim Coleman, Genevieve Baujat, Trevor R P Cole, Soma Das, Denise Horn, Helen E Hughes, I Karen Temple, Francesca Faravelli, Darrel Waggoner, Seval Turkmen, Valerie Cormier-Daire, Alexandre Irrthum, Nazneen Rahman.   

Abstract

We identified 266 individuals with intragenic NSD1 mutations or 5q35 microdeletions encompassing NSD1 (referred to as "NSD1-positive individuals"), through analyses of 530 subjects with diverse phenotypes. Truncating NSD1 mutations occurred throughout the gene, but pathogenic missense mutations occurred only in functional domains (P < 2 x 10(-16)). Sotos syndrome was clinically diagnosed in 99% of NSD1-positive individuals, independent of the molecular analyses, indicating that NSD1 aberrations are essentially specific to this condition. Furthermore, our data suggest that 93% of patients who have been clinically diagnosed with Sotos syndrome have identifiable NSD1 abnormalities, of which 83% are intragenic mutations and 10% are 5q35 microdeletions. We reviewed the clinical phenotypes of 239 NSD1-positive individuals. Facial dysmorphism, learning disability, and childhood overgrowth were present in 90% of the individuals. However, both the height and head circumference of 10% of the individuals were within the normal range, indicating that overgrowth is not obligatory for the diagnosis of Sotos syndrome. A broad spectrum of associated clinical features was also present, the occurrence of which was largely independent of genotype, since individuals with identical mutations had different phenotypes. We compared the phenotypes of patients with intragenic NSD1 mutations with those of patients with 5q35 microdeletions. Patients with microdeletions had less-prominent overgrowth (P = .0003) and more-severe learning disability (P = 3 x 10(-9)) than patients with mutations. However, all features present in patients with microdeletions were also observed in patients with mutations, and there was no correlation between deletion size and the clinical phenotype, suggesting that the deletion of additional genes in patients with 5q35 microdeletions has little specific effect on phenotype. We identified only 13 familial cases. The reasons for the low vertical transmission rate are unclear, although familial cases were more likely than nonfamilial cases (P = .005) to carry missense mutations, suggesting that the underlying NSD1 mutational mechanism in Sotos syndrome may influence reproductive fitness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942875      PMCID: PMC1224542          DOI: 10.1086/432082

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

Review 1.  The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation?

Authors:  I Stec; S B Nagl; G J van Ommen; J T den Dunnen
Journal:  FEBS Lett       Date:  2000-05-04       Impact factor: 4.124

2.  NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.

Authors:  Jenny Douglas; Sandra Hanks; I Karen Temple; Sally Davies; Alexandra Murray; Meena Upadhyaya; Susan Tomkins; Helen E Hughes; Trevor R P Cole; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2002-12-02       Impact factor: 11.025

3.  [''R"--project for statistical computing].

Authors:  Ram Benny Dessau; Christian Bressen Pipper
Journal:  Ugeskr Laeger       Date:  2008-01-28

4.  Sotos syndrome and haploinsufficiency of NSD1: clinical features of intragenic mutations and submicroscopic deletions.

Authors:  T Nagai; N Matsumoto; N Kurotaki; N Harada; N Niikawa; T Ogata; K Imaizumi; K Kurosawa; T Kondoh; H Ohashi; M Tsukahara; Y Makita; T Sugimoto; T Sonoda; T Yokoyama; K Uetake; S Sakazume; Y Fukushima; K Naritomi
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

5.  A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia.

Authors:  R J Jaju; C Fidler; O A Haas; A J Strickson; F Watkins; K Clark; N C Cross; J F Cheng; P D Aplan; L Kearney; J Boultwood; J S Wainscoat
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

6.  Haploinsufficiency of NSD1 causes Sotos syndrome.

Authors:  Naohiro Kurotaki; Kiyoshi Imaizumi; Naoki Harada; Mitsuo Masuno; Tatsuro Kondoh; Toshiro Nagai; Hirofumi Ohashi; Kenji Naritomi; Masato Tsukahara; Yoshio Makita; Tateo Sugimoto; Tohru Sonoda; Tomoko Hasegawa; Yasuaki Chinen; Hiro-aki Tomita Ha; Akira Kinoshita; Tsuyoshi Mizuguchi; Koh-ichiro Yoshiura Ki; Tohru Ohta; Tatsuya Kishino; Yoshimitsu Fukushima; Norio Niikawa; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

7.  NSD1 is essential for early post-implantation development and has a catalytically active SET domain.

Authors:  Geetha Vani Rayasam; Olivia Wendling; Pierre-Olivier Angrand; Manuel Mark; Karen Niederreither; Luyan Song; Thierry Lerouge; Gordon L Hager; Pierre Chambon; Régine Losson
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

8.  Spectrum of NSD1 mutations in Sotos and Weaver syndromes.

Authors:  M Rio; L Clech; J Amiel; L Faivre; S Lyonnet; M Le Merrer; S Odent; D Lacombe; P Edery; R Brauner; O Raoul; P Gosset; M Prieur; M Vekemans; A Munnich; L Colleaux; V Cormier-Daire
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

9.  Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome.

Authors:  K Tatton-Brown; J Douglas; K Coleman; G Baujat; K Chandler; A Clarke; A Collins; S Davies; F Faravelli; H Firth; C Garrett; H Hughes; B Kerr; J Liebelt; W Reardon; G B Schaefer; M Splitt; I K Temple; D Waggoner; D D Weaver; L Wilson; T Cole; V Cormier-Daire; A Irrthum; N Rahman
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

10.  Partial NSD1 deletions cause 5% of Sotos syndrome and are readily identifiable by multiplex ligation dependent probe amplification.

Authors:  J Douglas; K Tatton-Brown; K Coleman; S Guerrero; J Berg; T R P Cole; D Fitzpatrick; Y Gillerot; H E Hughes; D Pilz; F L Raymond; I K Temple; A Irrthum; J P Schouten; N Rahman
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

View more
  75 in total

1.  The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.

Authors:  Qi Qiao; Yan Li; Zhi Chen; Mingzhu Wang; Danny Reinberg; Rui-Ming Xu
Journal:  J Biol Chem       Date:  2010-12-31       Impact factor: 5.157

2.  Unbalanced der(5)t(5;20) translocation associated with megalencephaly, perisylvian polymicrogyria, polydactyly and hydrocephalus.

Authors:  Annemieke J M H Verkerk; Rachel Schot; Laura van Waterschoot; Hannie Douben; Pino J Poddighe; Maarten H Lequin; Linda S de Vries; Paulien Terhal; Johanne M D Hahnemann; Irenaeus F M de Coo; Marie-Claire Y de Wit; Leontien S Wafelman; Livia Garavelli; William B Dobyns; Peter J Van der Spek; Annelies de Klein; Grazia M S Mancini
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

Review 3.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

4.  Deletion of NSD1 exon 14 in Sotos syndrome: first description.

Authors:  Maria Piccione; Valeria Consiglio; Antonella Di Fiore; Marina Grasso; Massimiliano Cecconi; Lucia Perroni; Giovanni Corsello
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

5.  Novel missense mutation (L1917P) involving sac-domain of NSD1 gene in a patient with Sotos syndrome.

Authors:  Francesco Nicita; Luigi Tarani; Alberto Spalice; Marina Grasso; Laura Papetti; Massimiliano Cecconi; Claudio Di Biasi; Fabiana Ursitti; Paola Iannetti
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 6.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

7.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

Review 8.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

9.  A new familial cancer syndrome including predisposition to Wilms tumor and neuroblastoma.

Authors:  Fatemeh Abbaszadeh; Karen T Barker; Carmel McConville; Richard H Scott; Nazneen Rahman
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

10.  Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families.

Authors:  Virpi M Leppa; Stephanie N Kravitz; Christa Lese Martin; Joris Andrieux; Cedric Le Caignec; Dominique Martin-Coignard; Christina DyBuncio; Stephan J Sanders; Jennifer K Lowe; Rita M Cantor; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.